Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer

Published:2018-03 Issue: Volume:Volume 13 Page:1327-1339
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Bai Fang,Yin You,Chen Ting,Chen Jihui,Ge Meixin,Lu Yunshu,Xie Fangyuan,Zhang Jian,Wu Kejin,Liu Yan

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The encapsulation rate and pH sensitivity of arsenic were improved in liposome nanoparticles by the calcium acetate gradient method;PAK J PHARM SCI;2024

2. Recent advanced lipid-based nanomedicines for overcoming cancer resistance;Cancer Drug Resistance;2024-06-21

3. Cholesteryl ester transfer protein knock‐down in conjunction with a cholesterol‐depleting agent decreases tamoxifen resistance in breast cancer cells;IUBMB Life;2024-05-11

4. Synthesis of self-targeted carbon nanodot for efficient cancer cell imaging and therapy;Inorganic Chemistry Communications;2024-03

5. Remotely Rutin-Loaded into Liposomes for Efficient Encapsulation and Enhancement of Bioavailability and Brain Targeting in vivo;International Journal of Pharmacology;2023-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP